In-Silico Drug Discovery Market - Global Outlook and Forecast 2023-2027

Report ID: 684603 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 In-Silico Drug Discovery Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global In-Silico Drug Discovery Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global In-Silico Drug Discovery Overall Market Size
    2.1 Global In-Silico Drug Discovery Market Size: 2021 VS 2027
    2.2 Global In-Silico Drug Discovery Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top In-Silico Drug Discovery Players in Global Market
    3.2 Top Global In-Silico Drug Discovery Companies Ranked by Revenue
    3.3 Global In-Silico Drug Discovery Revenue by Companies
    3.4 Top 3 and Top 5 In-Silico Drug Discovery Companies in Global Market, by Revenue in 2020
    3.5 Global Companies In-Silico Drug Discovery Product Type
    3.6 Tier 1, Tier 2 and Tier 3 In-Silico Drug Discovery Players in Global Market
        3.6.1 List of Global Tier 1 In-Silico Drug Discovery Companies
        3.6.2 List of Global Tier 2 and Tier 3 In-Silico Drug Discovery Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global In-Silico Drug Discovery Market Size Markets, 2021 & 2027
        4.1.2 Software as a Service (Cloud)
        4.1.3 Consultancy as a Service
        4.1.4 Software
    4.2 By Type - Global In-Silico Drug Discovery Revenue & Forecasts
        4.2.1 By Type - Global In-Silico Drug Discovery Revenue, 2016-2021
        4.2.2 By Type - Global In-Silico Drug Discovery Revenue, 2022-2027
        4.2.3 By Type - Global In-Silico Drug Discovery Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global In-Silico Drug Discovery Market Size, 2021 & 2027
        5.1.2 Contract Research Organization
        5.1.3 Pharmaceutical Industry
        5.1.4 Academic and Research Institutes
        5.1.5 Others
    5.2 By Application - Global In-Silico Drug Discovery Revenue & Forecasts
        5.2.1 By Application - Global In-Silico Drug Discovery Revenue, 2016-2021
        5.2.2 By Application - Global In-Silico Drug Discovery Revenue, 2022-2027
        5.2.3 By Application - Global In-Silico Drug Discovery Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global In-Silico Drug Discovery Market Size, 2021 & 2027
    6.2 By Region - Global In-Silico Drug Discovery Revenue & Forecasts
        6.2.1 By Region - Global In-Silico Drug Discovery Revenue, 2016-2021
        6.2.2 By Region - Global In-Silico Drug Discovery Revenue, 2022-2027
        6.2.3 By Region - Global In-Silico Drug Discovery Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America In-Silico Drug Discovery Revenue, 2016-2027
        6.3.2 US In-Silico Drug Discovery Market Size, 2016-2027
        6.3.3 Canada In-Silico Drug Discovery Market Size, 2016-2027
        6.3.4 Mexico In-Silico Drug Discovery Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe In-Silico Drug Discovery Revenue, 2016-2027
        6.4.2 Germany In-Silico Drug Discovery Market Size, 2016-2027
        6.4.3 France In-Silico Drug Discovery Market Size, 2016-2027
        6.4.4 U.K. In-Silico Drug Discovery Market Size, 2016-2027
        6.4.5 Italy In-Silico Drug Discovery Market Size, 2016-2027
        6.4.6 Russia In-Silico Drug Discovery Market Size, 2016-2027
        6.4.7 Nordic Countries In-Silico Drug Discovery Market Size, 2016-2027
        6.4.8 Benelux In-Silico Drug Discovery Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia In-Silico Drug Discovery Revenue, 2016-2027
        6.5.2 China In-Silico Drug Discovery Market Size, 2016-2027
        6.5.3 Japan In-Silico Drug Discovery Market Size, 2016-2027
        6.5.4 South Korea In-Silico Drug Discovery Market Size, 2016-2027
        6.5.5 Southeast Asia In-Silico Drug Discovery Market Size, 2016-2027
        6.5.6 India In-Silico Drug Discovery Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America In-Silico Drug Discovery Revenue, 2016-2027
        6.6.2 Brazil In-Silico Drug Discovery Market Size, 2016-2027
        6.6.3 Argentina In-Silico Drug Discovery Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa In-Silico Drug Discovery Revenue, 2016-2027
        6.7.2 Turkey In-Silico Drug Discovery Market Size, 2016-2027
        6.7.3 Israel In-Silico Drug Discovery Market Size, 2016-2027
        6.7.4 Saudi Arabia In-Silico Drug Discovery Market Size, 2016-2027
        6.7.5 UAE In-Silico Drug Discovery Market Size, 2016-2027
7 Players Profiles
    7.1 Charles River
        7.1.1 Charles River Corporate Summary
        7.1.2 Charles River Business Overview
        7.1.3 Charles River In-Silico Drug Discovery Major Product Offerings
        7.1.4 Charles River In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.1.5 Charles River Key News
    7.2 Certara USA, Inc.
        7.2.1 Certara USA, Inc. Corporate Summary
        7.2.2 Certara USA, Inc. Business Overview
        7.2.3 Certara USA, Inc. In-Silico Drug Discovery Major Product Offerings
        7.2.4 Certara USA, Inc. In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.2.5 Certara USA, Inc. Key News
    7.3 Evotec
        7.3.1 Evotec Corporate Summary
        7.3.2 Evotec Business Overview
        7.3.3 Evotec In-Silico Drug Discovery Major Product Offerings
        7.3.4 Evotec In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.3.5 Evotec Key News
    7.4 Dassault System (Biovia)
        7.4.1 Dassault System (Biovia) Corporate Summary
        7.4.2 Dassault System (Biovia) Business Overview
        7.4.3 Dassault System (Biovia) In-Silico Drug Discovery Major Product Offerings
        7.4.4 Dassault System (Biovia) In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.4.5 Dassault System (Biovia) Key News
    7.5 Albany Molecular Research Inc. (AMRI)
        7.5.1 Albany Molecular Research Inc. (AMRI) Corporate Summary
        7.5.2 Albany Molecular Research Inc. (AMRI) Business Overview
        7.5.3 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Major Product Offerings
        7.5.4 Albany Molecular Research Inc. (AMRI) In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.5.5 Albany Molecular Research Inc. (AMRI) Key News
    7.6 Selvita
        7.6.1 Selvita Corporate Summary
        7.6.2 Selvita Business Overview
        7.6.3 Selvita In-Silico Drug Discovery Major Product Offerings
        7.6.4 Selvita In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.6.5 Selvita Key News
    7.7 Schrödinger, Inc.
        7.7.1 Schrödinger, Inc. Corporate Summary
        7.7.2 Schrödinger, Inc. Business Overview
        7.7.3 Schrödinger, Inc. In-Silico Drug Discovery Major Product Offerings
        7.4.4 Schrödinger, Inc. In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.7.5 Schrödinger, Inc. Key News
    7.8 GVK BIO
        7.8.1 GVK BIO Corporate Summary
        7.8.2 GVK BIO Business Overview
        7.8.3 GVK BIO In-Silico Drug Discovery Major Product Offerings
        7.8.4 GVK BIO In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.8.5 GVK BIO Key News
    7.9 OpenEye Scientific Software
        7.9.1 OpenEye Scientific Software Corporate Summary
        7.9.2 OpenEye Scientific Software Business Overview
        7.9.3 OpenEye Scientific Software In-Silico Drug Discovery Major Product Offerings
        7.9.4 OpenEye Scientific Software In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.9.5 OpenEye Scientific Software Key News
    7.10 Chemical Computing Group (CCG)
        7.10.1 Chemical Computing Group (CCG) Corporate Summary
        7.10.2 Chemical Computing Group (CCG) Business Overview
        7.10.3 Chemical Computing Group (CCG) In-Silico Drug Discovery Major Product Offerings
        7.10.4 Chemical Computing Group (CCG) In-Silico Drug Discovery Revenue in Global (2016-2021)
        7.10.5 Chemical Computing Group (CCG) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
107
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
In-Silico Drug Discovery Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
In-Silico Drug Discovery Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
In-Silico Drug Discovery Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports